James C. Blair, Director, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 980 shares at $5.00 ($5K) on 2013-01-30, disclosed to the SEC on 2013-02-01.
Scheduled sale ($5k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 367 | $2K | 38.9% |
| 2 | $4.71 | 613 | $3K | 61.1% |
| Total | $4.82 avg | 980 | $5K | 100% |
| Filing → |
| BNGO | BUY | 2018-08-27 | $92K | — | Filing → |
| CLVS | SELL | 2017-08-08 | $2.9M | — | Filing → |
| EVOK | SELL | 2016-05-27 | $1.6M | — | Filing → |